Maxigen Biotech (TPE:1783) Marketable Securities : NT$1.5 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Maxigen Biotech's Marketable Securities for the quarter that ended in Mar. 2025 was NT$1.5 Mil.

Maxigen Biotech's annual Marketable Securities declined from Dec. 2022 (NT$10.3 Mil) to Dec. 2023 (NT$1.5 Mil) but then stayed the same from Dec. 2023 (NT$1.5 Mil) to Dec. 2024 (NT$1.5 Mil).

Maxigen Biotech Marketable Securities Historical Data

The historical data trend for Maxigen Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Marketable Securities Chart

Maxigen Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

13.13

26.87

10.32

1.50

Maxigen Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															1.50	1.50	1.50	1.50	1.50

Maxigen Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Maxigen Biotech (TPE:1783) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Maxigen Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi.com.tw

Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is mainly engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products. It generates the majority of the revenue from the Biomedical products segment.

Maxigen Biotech Headlines

No Headlines